Charles Pauling Semba Dia Medica Therapeutics Inc. (DMAC) insider trading activity

DMAC Quotes by TradingView

Charles Pauling Semba is Director of DiaMedica Therapeutics Inc.. Currently has a direct ownership of 44,608 shares of DMAC, which is worth approximately $262,741. The most recent transaction as insider was on Jan 02, 2025, when has been sold 5,290 shares (Voting Common Shares, no par value per share) at a price of $5.34 per share, resulting in proceeds of $28,248. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 44.6K
13.45% 3M change
13.45% 12M change
Total Value Held $262,741

Charles Pauling Semba Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2025
BUY
Grant, award, or other acquisition
$28,248 $5.34 p/Share
5,290 Added 10.6%
44,608 Voting Common Shares, ...
Jan 02 2024
BUY
Grant, award, or other acquisition
$26,250 $2.8 p/Share
9,375 Added 19.25%
39,318 Voting Common Shares, ...
Jun 23 2023
BUY
Open market or private purchase
$49,997 $3.91 p/Share
12,787 Added 29.93%
29,943 Voting Common Shares, ...
Jan 03 2023
BUY
Grant, award, or other acquisition
$26,248 $1.53 p/Share
17,156 Added 50.0%
17,156 Voting Common Shares, ...
CPS

Charles Pauling Semba

Director
Minneapolis, MN

Track Institutional and Insider Activities on DMAC

Follow DiaMedica Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DMAC shares.

Notify only if

Insider Trading

Get notified when an Dia Medica Therapeutics Inc. insider buys or sells DMAC shares.

Notify only if

News

Receive news related to DiaMedica Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DMAC